Expectations of what it means to drive a sustainable business are evolving rapidly. The COVID-19 pandemic, access to care and the climate crisis have accelerated demands for the private sector to demonstrate how it adds value to society and mitigates long-term risks. Novo Nordisk is at the forefront of these challenges – and we are stepping up our commitments to patients and society as we further integrate sustainability into everything we do.
Investors
Share price
{{priceData.date}} {{priceData.time}}
a. Sustainalytics: Copyright © 2024 Sustainalytics, a
Morningstar company. All rights reserved. This page includes
information and data provided by Sustainalytics and/or its content
providers. Information provided by Sustainalytics is not directed to
or intended for use or distribution to India-based clients or users
and its distribution to Indian resident individuals or entities is not
permitted.
Morningstar/Sustainalytics accepts no responsibility or
liability whatsoever for the actions of third parties in this respect.
Use of such data is subject to conditions available at https://www.sustainalytics.com/legal-disclaimers/
b. MSCI: The use by Novo Nordisk of any MSCI ESG RESEARCH LLC or its affiliates (“MSCI”) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of Novo Nordisk by MSCI. MSCI services and data are the property of MSCI or its information providers and are provided ‘as-is’ and without warranty. MSCI names and logos are trademarks or service marks of MSCI.